
Humacyte
Global leader in engineering regenerative medicine products to save and improve patient lives.
Market cap
$327m
Enterprise value
$280m
Share price
$2.09 HUMA
Authorizing premium user...
Global leader in engineering regenerative medicine products to save and improve patient lives.